Title : Efficacy and safety of ezetimibe in patients undergoing hemodialysis.

Pub. Date : 2010

PMID : 20885068






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Compared to baseline values, LDL-cholesterol (LDL-C) was reduced by 24.9% (p<0.005) after 12 weeks of ezetimibe administration. Ezetimibe component of oligomeric golgi complex 2 Homo sapiens
2 Compared to baseline values, LDL-cholesterol (LDL-C) was reduced by 24.9% (p<0.005) after 12 weeks of ezetimibe administration. Ezetimibe component of oligomeric golgi complex 2 Homo sapiens
3 A highly significant correlation was observed between alterations in LDL-C and campesterol levels in response to ezetimibe therapy. Ezetimibe component of oligomeric golgi complex 2 Homo sapiens